Additional file 4: Figure S3. of Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
收藏数据链接：
官方服务：
资源简介：
OS according to site of origin (ODP 16 kb)
按起源位点划分的总生存期（Overall Survival）（ODP 16 kb）
创建时间：
2016-12-15
